BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12761049)

  • 21. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
    Cáceres JF; Stamm S; Helfman DM; Krainer AR
    Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intron sequences and the length of the downstream second exon affect the binding of hnRNP C proteins in an in vitro splicing reaction.
    Goswami P; Goldenberg CJ
    Nucleic Acids Res; 1988 Jun; 16(11):4995-5011. PubMed ID: 3290845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.
    Topp JD; Jackson J; Melton AA; Lynch KW
    RNA; 2008 Oct; 14(10):2038-49. PubMed ID: 18719244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Srrm234, but not canonical SR and hnRNP proteins, drive inclusion of
    Ustaoglu P; Haussmann IU; Liao H; Torres-Mendez A; Arnold R; Irimia M; Soller M
    RNA; 2019 Oct; 25(10):1353-1365. PubMed ID: 31292260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation of PTB binding sites causes misregulation of alternative 3' splice site selection in vivo.
    Pérez I; Lin CH; McAfee JG; Patton JG
    RNA; 1997 Jul; 3(7):764-78. PubMed ID: 9214659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative splicing of a human alpha-tropomyosin muscle-specific exon: identification of determining sequences.
    Graham IR; Hamshere M; Eperon IC
    Mol Cell Biol; 1992 Sep; 12(9):3872-82. PubMed ID: 1508190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of the ubiquitous alternative splicing factor Tra2beta causes inclusion of a germ cell-specific exon.
    Venables JP; Bourgeois CF; Dalgliesh C; Kister L; Stevenin J; Elliott DJ
    Hum Mol Genet; 2005 Aug; 14(16):2289-303. PubMed ID: 16000324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
    Simard MJ; Chabot B
    Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.
    Caputi M; Mayeda A; Krainer AR; Zahler AM
    EMBO J; 1999 Jul; 18(14):4060-7. PubMed ID: 10406810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.
    Caputi M; Zahler AM
    EMBO J; 2002 Feb; 21(4):845-55. PubMed ID: 11847131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition.
    Heiner M; Hui J; Schreiner S; Hung LH; Bindereif A
    RNA Biol; 2010; 7(1):56-64. PubMed ID: 19946215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon.
    Gooding C; Roberts GC; Smith CW
    RNA; 1998 Jan; 4(1):85-100. PubMed ID: 9436911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome.
    Bian Y; Masuda A; Matsuura T; Ito M; Okushin K; Engel AG; Ohno K
    Hum Mol Genet; 2009 Apr; 18(7):1229-37. PubMed ID: 19147685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The generally expressed hnRNP F is involved in a neural-specific pre-mRNA splicing event.
    Min H; Chan RC; Black DL
    Genes Dev; 1995 Nov; 9(21):2659-71. PubMed ID: 7590243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein.
    Markovtsov V; Nikolic JM; Goldman JA; Turck CW; Chou MY; Black DL
    Mol Cell Biol; 2000 Oct; 20(20):7463-79. PubMed ID: 11003644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HnRNP L represses exon splicing via a regulated exonic splicing silencer.
    Rothrock CR; House AE; Lynch KW
    EMBO J; 2005 Aug; 24(15):2792-802. PubMed ID: 16001081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7.
    Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H
    Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A modeling study of co-transcriptional metabolism of hnRNP using FMR1 gene.
    Ro-Choi TS; Choi YC
    Mol Cells; 2007 Apr; 23(2):228-38. PubMed ID: 17464201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms.
    Erkelenz S; Mueller WF; Evans MS; Busch A; Schöneweis K; Hertel KJ; Schaal H
    RNA; 2013 Jan; 19(1):96-102. PubMed ID: 23175589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron.
    Loh TJ; Cho S; Moon H; Jang HN; Williams DR; Jung DW; Kim IC; Ghigna C; Biamonti G; Zheng X; Shen H
    Biochim Biophys Acta; 2015 Jun; 1849(6):743-50. PubMed ID: 25623890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.